In the rapidly advancing field of cancer gene therapy, this meeting is ideal for keeping abreast of new developments and recent gene therapy clinical trials. The talks were particularly focused on clinical trials and clinical applications of gene therapy, and, with attendance kept to less than 300 delegates, there was ample opportunity for informal discussions. One afternoon devoted only to poster sessions allowed delegates to learn of the most recent results. For individuals desiring to know the latest about clinical gene therapy trials, this meeting is highly recommended. All in all, the meeting was excellent as usual.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Feb 1 2003|
ASJC Scopus subject areas
- Drug Discovery